Xavier's RCMI Cancer Research Program

泽维尔的 RCMI 癌症研究计划

• 批准号: 8103611
• 负责人: Gene D'Amour
• 金额: $ 52万
• 依托单位: XAVIER UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-05 至 2012-08-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8103611
• 关键词: Xavier; RCMI; Cancer; Research; Program

In the past decade, Xavier University of Louisiana has embarked on an ambitious, strategic initiative to enhance its research competitiveness in biomedical fields. Our long term goal is to, in the next 5 to 7 years, be seen nationally not only for our eminence in graduating African American science, pre-med and pharmacy students, but also for national prominence in cancer research. Since 2002, in spite of the destruction rendered by Katrina, Xavier has made significant advances toward achieving this goal through the establishment of both the Center for Minority Health Disparities, launched in 2002, and through membership in the Louisiana Cancer Research Consortium. Xavier researchers have received significant external funding for cancer research from the National Institutes of Health, Department of Defense, National Cancer Institute, and Louisiana Board of Regents, among others. To determine what next steps needed to be taken to build on the above-described progress and take Xavier "to the next level," a comprehensive RCMI planning process was carried out through faculty and staff surveys, focus groups, and forums, with the assistance of a variety of external advisors. As a result, barriers to competitiveness and strategies to overcoming them were identified in such areas as recruiting and retaining research competitive faculty, infrastructural support for biomedical research, and lack of centralized core laboratories with supporting staff. To address these barriers, this proposal requests funding to assist Xavier in: (1) increasing the number and quality of Cancer researchers and providing them with start-up packages, release time, and mentoring opportunities; 2) enhancing the competitiveness of existing research faculty and programs by providing seed funding for developmental projects, enhanced professional development opportunities and increased access to postdoctoral associates and research staff; (3) developing three research instrumentation cores; (4) offering enhanced administrative services to assure research support activities meet faculty needs, and (5) supporting selected pilot projects that will assist investigators who are at the "cusp" of becoming fully competitive

在过去的十年中，路易斯安那州泽维尔大学实施了一项雄心勃勃的战略举措，以增强其在生物医学领域的研究竞争力。我们的长期目标是，在未来 5 到 7 年内，不仅要在全国范围内看到我们在非洲裔美国科学、医学预科和药学专业毕业生方面的杰出表现，而且还要在全国范围内的癌症研究方面表现突出。自 2002 年以来，尽管卡特里娜飓风造成了破坏，但泽维尔通过建立 2002 年启动的少数族裔健康差异中心以及加入路易斯安那州癌症研究联盟，在实现这一目标方面取得了重大进展。泽维尔研究人员从美国国立卫生研究院、国防部、国家癌症研究所和路易斯安那州董事会等机构获得了大量用于癌症研究的外部资金。为了确定下一步需要采取哪些步骤，以在上述进展的基础上再接再厉，并将 Xavier 提升到“一个新的水平”，在教职员工调查、焦点小组和论坛的协助下，进行了全面的 RCMI 规划流程。各种外部顾问。因此，在招聘和留住有研究竞争力的教师、生物医学研究的基础设施支持以及缺乏配备支持人员的集中核心实验室等领域，确定了竞争力的障碍和克服这些障碍的战略。为了解决这些障碍，该提案要求提供资金来协助泽维尔：（1）增加癌症研究人员的数量和质量，并为他们提供启动包、发布时间和指导机会； 2）通过为发展项目提供种子资金、增加专业发展机会以及增加获得博士后和研究人员的机会，提高现有研究人员和项目的竞争力； （3）开发三个研究仪器核心； (4) 提供强化的行政服务，以确保研究支持活动满足教师的需求，以及 (5) 支持选定的试点项目，以帮助处于充分竞争“风口浪尖”的研究人员